Gilead Sciences Profit Margin

Gilead Sciences (GILD) currently reports a profit margin of -10.64% as of June 2026. That compares with 21.86% in the prior-year period — down 148.7% year over year. That is below the Healthcare sector average of 13.39%. Use the charts on this page to explore Gilead Sciences's profit margin history and peer comparisons.

Gilead Sciences's profit margin decreased from 21.86% to -10.64% — a 148.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gilead Sciences's profit margin of -10.64% is lower than the Healthcare sector average of 13.39%. That is roughly 179.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Gilead Sciences's current -10.64% should be judged against Healthcare norms (sector average: 13.39%) and against GILD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -10.64%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.39%. From there, open related valuation or income-statement pages for Gilead Sciences, and consider following GILD for alerts when major investors trade the stock.